MINNEAPOLIS - April 30, 2007 - Raymedica, the Pioneer in Nucleus Arthroplasty, announced today that Volume II, Biomechanics & Development and Volume III, Surgical Techniques & Technologies in the ground-breaking 4-Volume Series entitled, “Nucleus Arthroplasty™ Technology in Spinal Care” will be released at the Spine Arthroplasty Society 7th (SAS7) Annual Conference being held in Berlin, Germany, May 1-4, 2007. The complimentary publications will be made available at Raymedica Booth # 21.

Raymedica has jointly produced and published Volumes II & III of the 4-Volume series entitled, “Nucleus Arthroplasty Technology in Spinal Care” with the Deputy Review Board of Reginald J. Davis, MD, FACS; Federico P. Girardi, MD; Frank P. Cammisa, Jr. MD, FACS and William C. Hutton, DSc. Their constructive and creative guidance in the selection of relevant materials will influence nucleus arthroplasty technology and its impact on non-fusion spine surgery.

“The series is a great resource because it allows the individual to read and download copies about Nucleus Arthroplasty Technology from respected and esteemed group of authors.” stated John J. Viscogliosi, Chairman and Chief Executive Officer of Raymedica, LLC.

“We are reaching innovators and early adopters who are actively searching for better ways to meet their patient needs.” Mr. Viscogliosi continued, “The series is a natural resource for educational information designed to provide valuable guidance to spine surgeons as they seek to provide more effective and less invasive options for the treatment of degenerative disc disease (DDD).”

About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus Arthroplasty having developed the world’s first nucleus replacement device in 1996. Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have been unresponsive to non-surgical treatment. Raymedica’s products are currently available in many countries worldwide, but are limited to investigational use only in the United States. For more information, visit the Company's website at

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.

> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.